Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study

BACKGROUND AND AIMS: Individualization of treatment with peginterferon alfa and ribavirin in patients with chronic hepatitis C showed benefit in controlled trials and was implemented in treatment guidelines to increase response rates and to reduce side effects and costs. However, it is unknown wheth...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofmann, Wolf Peter, Mauss, Stefan, Lutz, Thomas, Schober, Andreas, Böker, Klaus, Moog, Gero, Baumgarten, Axel, Pfeiffer-Vornkahl, Heike, Alshuth, Ulrich, Hüppe, Dietrich, Wedemeyer, Heiner, Manns, Michael P., Schott, Eckart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521757/
https://www.ncbi.nlm.nih.gov/pubmed/26230998
http://dx.doi.org/10.1371/journal.pone.0134839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521757/
https://www.ncbi.nlm.nih.gov/pubmed/26230998
http://dx.doi.org/10.1371/journal.pone.0134839

Ejemplares similares